Group 1 - The core point of the article is that JinHao Medical (stock code: 920925) experienced a significant price increase of 20.03% on January 5, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" [1][3] - The trading volume for JinHao Medical on that day reached 10.8265 million shares, with a total transaction value of 394 million yuan [1][2] - The top buying position was held by Huatai Securities Co., Ltd. with a purchase amount of approximately 13.12 million yuan, while the top selling position was held by Debon Securities Co., Ltd. with a selling amount of approximately 15.54 million yuan [1][2] Group 2 - The article provides detailed trading data, including the top five buying and selling brokerage firms, highlighting significant transactions from various securities companies [2] - Notably, the second-largest buying position was from China Galaxy Securities with approximately 11.51 million yuan, and the third from Dongfang Securities with about 10.48 million yuan [2] - On the selling side, the second-largest selling position was from Guosen Securities with approximately 15.24 million yuan, indicating a competitive trading environment [2]
北交所上市公司锦好医疗登龙虎榜：当日收盘价涨幅达到20.03%